Page last updated: 2024-09-04

ml-3000 and sb 220025

ml-3000 has been researched along with sb 220025 in 1 studies

Compound Research Comparison

Studies
(ml-3000)
Trials
(ml-3000)
Recent Studies (post-2010)
(ml-3000)
Studies
(sb 220025)
Trials
(sb 220025)
Recent Studies (post-2010) (sb 220025)
1309562907

Protein Interaction Comparison

ProteinTaxonomyml-3000 (IC50)sb 220025 (IC50)
Chain A, MAP KINASE P38Homo sapiens (human)9.0095
Chain A, PROTEIN (MAP KINASE P38)Homo sapiens (human)9.0095
Chain A, PROTEIN (MAP KINASE P38)Homo sapiens (human)9.0095
Chain A, Protein (map Kinase P38)Homo sapiens (human)9.0095
Chain A, Extracellular Regulated Kinase 2Rattus norvegicus (Norway rat)9.0095
Chain A, Extracellular Regulated Kinase 2Rattus norvegicus (Norway rat)9.0095
Mitogen-activated protein kinase 13Homo sapiens (human)0.019
Mitogen-activated protein kinase 12Homo sapiens (human)0.019
Mitogen-activated protein kinase 1Rattus norvegicus (Norway rat)0.019
Mitogen-activated protein kinase 11Homo sapiens (human)0.019
Mitogen-activated protein kinase 14Homo sapiens (human)0.0193

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1

Other Studies

1 other study(ies) available for ml-3000 and sb 220025

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013